Lung Cancer Considered

By IASLCScience

Lung Cancer Considered episodes

October 09 LCC in Arabic: Joint IASLC/EMRO Workshop Highlights From WCLC 2026
The WHO Eastern Mediterranean Region (EMRO) faces unique challenges around exposures, non-conventional smoking, lung cancer screening, molecular profiling, and evolving therapies in lung cancer. To address this, the inaugural joint IASLC/EMRO workshop took place at the 2026 World Conference on Lung Cancer (WCLC) in Seoul.
In this episode, Dr. Nagla Karim discusses highlights from the workshop in Arabic with Dr. Hesham Elghazaly, Dr. Arafat Tfayli, Dr. Bashir Abu Aqeel, Dr. Riad Abdel Jalil, Dr. Adda Bounedjar, and Dr. Rasha Aboelhassan.
Guests:
Nagla Karim, MD
Professor of Medicine
Director of Thoracic Oncology and Phase I Programs
George Washington University
Hesham Elghazaly, MD
Professor of Clinical Oncology
Ain Shams University
Arafat Tfayli, MD
Chief of Hematology/Oncology and Professor of Clinical Medicine
American University of Beirut Medical Center
Bashir Abu Aqeel, MD
Medical Oncologist
Augusta Victoria Hospital
Riad Abdel Jalil, MD
Thoracic Surgeon
King Hussein Cancer Center
Adda Bounedjar, MD
Professor of Medical Oncology
Blida 1 University
Rasha Aboelhassan, MD
Senior Oncology Consultant
Nasser Institute for Research and Treatment
38 min
October 06 LCC in Korean WCLC 2026 Highlights
The 2026 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages.
In this episode, host Dr. Chul Kim moderates a discussion in Korean about breakthrough advances in thoracic oncology presented at the conference with Dr. Ji-Youn Han, Dr. Tae Min Kim, and Dr. Sehhoon Park.
Guests:
Ji-Youn Han, MD, PhD
Professor
National Cancer Center of Korea
X: @oncologyhan
Tae Min Kim, MD, PhD
Professor
Seoul National University Hospital
No Social
Sehhoon Park, MD, PhD
Division of Hematology-Oncology, Department of Medicine
Samsung Medical Center, Sungkyunkwan University School of Medicine
LinkedIn: https://www.linkedin.com/in/sehhoon-park/
46 min
October 05 WCLC 2026 Patient Advocate Takeover: Centering Patient Voices in Research and Care
In this special Patient Advocate Takeover episode, recorded at the 2026 IASLC World Conference on Lung Cancer in Seoul, patient advocates Dr. Sydney Barned and Yvonne Diaz discuss the research and conversations that caught their attention at the meeting.
They reflect on access to new therapies, the importance of involving patient advocates early in clinical trial design, and how stronger communication between patients and providers can improve care. Plus, hear what they look for in new research and their perspectives on topics such as survivorship research and exercise oncology.
Guests:
Dr. Sydney Barned
Physician and Patient Advocate
Living with Stage IV ALK-positive lung cancer
Yvonne Diaz
Co-founder and Chair, Oncogene Cancer Research
Board Member, ALK Positive Inc.
25 min
October 01 WCLC 2026 East-West Academic Exchange: Collaborating on the Future of Lung Cancer Care
Recorded live at the IASLC World Conference on Lung Cancer (WCLC) 2026 in Seoul, this episode brings together experts from China and the U.S. to discuss the growing exchange of ideas, research, and clinical expertise between the regions.
Dr. Chul Kim, Dr. Stephen Liu, Dr. Yuanyuan Zhao, and Dr. Caicun Zhou discuss key research highlights presented at WCLC and explore why lung cancer research is advancing rapidly in China, plus how stronger global collaboration can shape the future of thoracic oncology.
Guests:
Dr. Chul Kim
Director of Thoracic Oncology
Georgetown University, Washington, DC
Dr. Yuanyuan Zhao
Medical Oncologist & Chief Physician
Sun Yat-Sen University Cancer Center
Dr. Caicun Zhou
Professor, Chief Physician, and Director of Medical Oncology
Shanghai Pulmonary Hospital, Tongji University School of Medicine
35 min
September 29 WCLC 2026 Nurse Practitioner Takeover: What APPs are Taking Back to the Clinic
Recorded at the 2026 IASLC World Conference on Lung Cancer in Seoul, this special Nurse Practitioner takeover episode looks at key developments in small cell lung cancer, antibody-drug conjugates, and lung cancer screening — with a focus on what APPs can take back to the clinic.
Laura Macke, Stephanie McDonald, and Dr. Mary Pasquinelli discuss the studies and advances that caught their attention, including how these developments will affect patient conversations, treatment decisions, and the day-to-day work of APPs.
Guests:
Laura A. Macke, MS, FNP-C, AOCNP
Nurse Practitioner
Medstar Georgetown Cancer Institute
Washington, DC
Stephanie McDonald, MSN, FNP-BC, AOCNP
Thoracic Oncology Nurse Practitioner
Dana-Farber Cancer Institute
Boston, MA
Mary Pasquinelli, DNP, APRN, CTTS
Lead Nurse Practitioner and Director of the Lung Screening Program
University of Illinois Chicago
45 min
September 24 LCC in Czech: WCLC 2026 Highlights
The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research.
To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages.
In this episode, host Dr. Marie Drösslerová moderates a discussion in Czech about breakthrough advances in thoracic oncology presented at the conference with Dr. Fernando Casas Mendez and Dr. Martin Svaton.
Guests:
Marie Drösslerová, MD
Clinical Oncologist and Pulmonologist, Department of Pulmonology, First Faculty of Medicine
Charles University/Thomayer University Hospital, Prague
Fernando Casas Mendez, MD
Pulmonologist, Center for Thoracic Oncology and Surgery & National Oncology Center
University Hospital Motol and Homolka, Prague
Martin Svaton, Ph.D.
Department of Pneumology and Phtiseology
University Hospital in Pilsen
11 min
September 17 LCC in Spanish: WCLC 2026 Highlights
The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research.
To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages.
In this episode, host Dr. Narjust Florez moderates a discussion in Spanish about breakthrough advances in thoracic oncology presented at the conference with Dr. Jorge Alatorre Alexander and Dr. Miguel Gonzalez Velez.
Guests:
Jorge Alatorre Alexander, MD
Head of the Medical Oncology Service
National Institute of Respiratory Diseases (INER)
Miguel Gonzalez Velez, MD
Medical Oncologist
John Theurer Cancer Center at Hackensack University Medical Center
49 min
September 17 LCC in Portuguese: WCLC 2026 Highlights
The 2026 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research.
To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages.
In this episode, host Dr. Clarissa Mathias moderates a discussion in Portuguese about breakthrough advances in thoracic oncology presented at the conference with Dr. Lilian Faroni and Dr. Vladmir Cordeiro de Lima.
Guests:
Lilian Faroni, MD, PhD
Radiation Oncologist
Oncologia D’Or Rio de Janeiro, Brazil
Vladmir Cordeiro de Lima, MD, PhD
Thoracic and Breast Oncologist
A.C. Camargo Cancer Center, São Paulo, Brazil
29 min
September 15 Live From WCLC 2026: Tuesday Highlights & Meeting Summary
In this special WCLC 2026 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu recap key findings from day three of the conference, featuring major advances that move targeted therapies earlier in the treatment of lung cancer.
Guests Dr. Julia Rotow, Dr. Roy Herbst, and Dr. Daniel Tan discuss new data from DESTINY-Lung04, ADAURA, and REZILIENT3 and what these findings could mean for clinical practice.
Guests:
Dr. Julia Rotow
Clinical Director and Research Director, Lowe Center for Thoracic Oncology
Dana-Farber Cancer Institute
Dr. Roy Herbst
Director, Dartmouth Cancer Center
Professor, Geisel School of Medicine at Dartmouth
Dr. Daniel Shao-Weng Tan
Senior Consultant Medical Oncologist at Division of Medical Oncology, National Cancer Centre Singapore
Professor, Duke-NUS Medical School
Senior Clinician-Scientist, Genome Institute of Singapore
45 min
September 15 LCC in Mandarin: WCLC 2026 Highlights
The 2026 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research.
To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages.
In this episode, host Dr. Chunxia Su moderates a discussion in Mandarin Chinese about breakthrough advances in thoracic oncology presented at the conference with Dr. Zhengfei Zhu, Dr. Yun Fan, and Dr. Dongsheng Yue.
Guests:
Dr. Yun Fan, MD, PhD
Chief Expert of the Multidisciplinary Lung Cancer Team, Zhejiang Cancer Hospital;
Senior Consultant (Grade II Chief Physician); Doctoral Supervisor
Dr. Dongsheng Yue, MD, PhD
Tianjin Medical University Cancer Institute and Hospital
Dr. Zhengfei Zhu, MD, PhD
Department of Radiation Oncology
Fudan University Shanghai Cancer Center
38 min

About Lung Cancer Considered

From the publisher's feed

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.